Patients With Alzheimer's Disease or Related Youth Disease

Lewy Body Disease Clinical Trial

— PARMAAJJ  

Official title:

Patients With Alzheimer's Disease or Related Youth Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03508024
• Other study ID #: NI_2016_39
• Secondary ID: 2017-A00486-47
• Status: Completed
• Start date: January 5, 2018
• Est. completion date: April 25, 2019

Study information

• Verified date: April 2018
• Source: University Hospital, Lille
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to determine factors related to diagnosis delay for patients with young onset dementia (first symptoms before 60 years old) who live in North of France.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 220
• Est. completion date: April 25, 2019
• Est. primary completion date: April 25, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

As part of this study, patients will be considered:

• Residing in the departments of Nord (59) and Pas-de-Calais (62),
• whose diagnosis of Alzheimer's disease or related illness (DLFT, DCL) was made and announced,
• Whose diagnosis of illness was made after 2007
• whose first symptoms appeared before the age of 60 Patients included in the COMAJ cohort and those who completed the Pathways medical and social booklet will have to meet these criteria to be selected for this study. As part of the survey, caregivers of patients meeting the above criteria and the following

two will be recruited:

• Having consulted or being followed by liberal neurologists or in hospital memory consultations (excluding CMRR-CNR-MAJ Lille) of the departments of Nord and Pas-de-Calais,
• Not monitored at the CMRR-CNR-MAJ Lille (ad hoc notice possible). The caregiver is defined as a family member or friend who helps regularly by doing the necessary tasks so that the sick person can keep as much autonomy as possible.

Exclusion Criteria:

• aged under 18
• no social coverage
• refusal to sign informed consent form

Related Conditions & MeSH terms

• Alzheimer Disease
• Alzheimer Disease, Early Onset
• Frontotemporal Lobar Degeneration
• Lewy Body Disease

Locations

Country	Name	City	State
France	Hôpital Roger Salengro, CHRU	Lille

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the delay between the diagnosis and the first symptomsIdentification of factors related with diagnosis delay	To determine the factors associated with diagnostic delay in young patients (early symptoms before age 60) with Alzheimer's disease or related degenerative disease (Fronto-temporal Lobar Degeneration , Lewy Body Dementia )	10 years
Secondary	Comparison of patient profiles followed at the CMRR-CNR-MAJ Lille and those who are not.	The different profiles are defined according to composite measures of socio-demographic type	10 years
Secondary	Comparison of patients characteristics followed at the CMRR-CNR-MAJ Lille and those who are not.Impact of the diagnosis on YOD	The different characteristics are defined according to composite measures of socio-demographic type	10 years
Secondary	the percentage of patients who have had a lack of information about the disease and possible aids	Identification of medico-social issues taht have been encountered by YOD patients during the care	10 years
Secondary	the percentage of refusal or delay of treatment of certain medico-social aids by the competent authorities	Identification of medico-social issues taht have been encountered by YOD patients during the care	10 years